COMPANY

Press Releases

Intact Vascular Announces Publication of TOBA III Clinical Trial Results in the Journal of Vascular Surgery
Peer-Reviewed Article Validates Tack Endovascular System® as a Clinically Important Treatment for Post-Angioplasty Dissection Repair in Above-the-Knee Complex Lesions

May 13, 2020 WAYNE, Pa.–(BUSINESS WIRE)– Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the peer-reviewed publication of its Tack Optimized Balloon Angioplasty (TOBA) III 12-month clinical trial results in

Read More »

Journal of Endovascular Therapy Publishes Peer Reviewed Article Underscoring the Clinical Impact of Post-Angioplasty DissectionsIntact Vascular’s Tack Endovascular System® is highlighted as a treatment option for post-PTA dissections

June 18, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the peer-reviewed  publication, “Dissections After Infrainguinal Percutaneous Transluminal Angioplasty (PTA): Systematic Review and Current State of

Read More »

Journal of Endovascular Therapy Publishes Peer Reviewed Article Underscoring the Clinical Impact of Post-Angioplasty DissectionsIntact Vascular’s Tack Endovascular System® is highlighted as a treatment option for post-PTA dissections

June 18, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the peer-reviewed  publication, “Dissections After Infrainguinal Percutaneous Transluminal Angioplasty (PTA): Systematic Review and Current State of

Read More »

Intact Vascular to Announce One-Year Data from TOBA III Clinical TrialStudy Investigates Use of the Tack Endovascular System® for Focal Dissection Repair Following Drug-Coated Balloon Angioplasty in PAD Patients

September 16, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year data from its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial will be

Read More »

Intact Vascular to Announce Six-Month Data from TOBA II BTK Clinical TrialFirst Pivotal Study to Investigate Permanent Vascular Implant as a Treatment for Post-Angioplasty Dissections in Arteries Below the Knee (BTK) 

October 22, 2019 – WAYNE, Pa.–(BUSINESS WIRE)– Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the six-month data from its Tack Optimized Balloon Angioplasty (TOBA) II BTK clinical trial

Read More »

PURPOSEBUILT. PRECISION REPAIR. PRESERVES OPTIONS.

Scroll to Top
Intact Vascular uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this.